Anoro Ellipta

Anoro Ellipta is a combination inhaler containing Umeclidinium Bromide and Vilanterol, used for managing chronic obstructive pulmonary disease (COPD). This maintenance medication helps improve breathing and reduce symptoms. Learn more about Anoro Ellipta's benefits and uses.

Anoro Ellipta is primarily used for the long-term management of chronic obstructive pulmonary disease (COPD). This medication combines Umeclidinium Bromide, an anticholinergic, and Vilanterol, a long-acting beta-agonist, to help open airways and improve breathing. People often ask, 'What is Anoro Ellipta used for?' It is designed for daily use to maintain lung function and reduce COPD flare-ups.

Common effects of Anoro Ellipta may include throat irritation, cough, and headache. Some users experience dry mouth or muscle spasms. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Anoro Ellipta should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Do not use Anoro Ellipta for acute symptoms or sudden breathing problems. Keep the inhaler out of reach of children and store it properly.

Anoro Ellipta may interact with other medications, including beta-blockers, anticholinergics, and certain antidepressants. Always inform your healthcare provider about all medications you are taking. Avoid using Anoro Ellipta with other long-acting beta-agonists unless directed.